Send us a text

Major stories developing on the global economic front, including:

•  Wall Street Divided on Fed Hikes
• US Government Shutdown for Christmas?
• Wegovy Proves Health is Wealth
• Moody’s Grim Forecast
• The SECs Crypto Crackdown 

FinWeekly has all the latest news about the market and finance this week: In this week's episode, we navigate the dynamic landscape of Wall Street, dissecting contrasting opinions on the Federal Reserve's potential interest rate moves in 2024. Morgan Stanley and UBS advocate for significant cuts due to slowing inflation and a sluggish economy, while Goldman Sachs adopts a more cautious stance. Shifting gears, we explore the averted threat of a government shutdown on November 18, attributing the reprieve to House Speaker Mike Johnson's temporary funding proposal, emphasizing the importance of bipartisan cooperation for economic stability. Additionally, we delve into Novo Nordisk's financial triumph with their Wegovy weight-loss drug, witnessing a staggering $14.5 billion market value surge. Addressing economic concerns, we unpack Moody's recent shift in the US credit rating outlook, expressing apprehension about substantial deficits without spending cuts or increased revenue. Lastly, we highlight positive news for investors as the SEC flexes its regulatory muscles, securing nearly $5 billion in fines and paybacks during fiscal year 2023, particularly scrutinizing Wall Street and major players in the crypto arena. Stay tuned for more updates and insights.


Here's how to get started with Boosting Your Financial IQ:

• Step 1:  Test your financial IQ for FREE
• Step 2:  Download the FREE app
• Step 3:  Take the Fundamentals of Finance course

Disclaimer:
BYFIQ, LLC is a wholly owned entity of Coltivar Group, LLC. The views expressed here are those of the individual Coltivar Group, LLC (“Coltivar”) personnel quoted and are not the views of Coltivar or its affiliates. Certain information contained in here has been obtained from third-party sources. While taken from sources believed to be reliable, Coltivar has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation.

This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendations. The Company is not affiliated with, nor does it receive compensation from, any specific security. Please see https://www.byfiq.com/terms-and-privacy-policy for additional important information.

Want to see if you’re a fit for our KPI Kickoff? Check it out here: https://www.coltivar.com/boost

Support the show